Gerhard Erkel

1.5k total citations
66 papers, 1.2k citations indexed

About

Gerhard Erkel is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Gerhard Erkel has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pharmacology, 36 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Gerhard Erkel's work include Microbial Natural Products and Biosynthesis (27 papers), Fungal Biology and Applications (13 papers) and Cytokine Signaling Pathways and Interactions (10 papers). Gerhard Erkel is often cited by papers focused on Microbial Natural Products and Biosynthesis (27 papers), Fungal Biology and Applications (13 papers) and Cytokine Signaling Pathways and Interactions (10 papers). Gerhard Erkel collaborates with scholars based in Germany, Sweden and Brazil. Gerhard Erkel's co-authors include Timm Anke, Olov Sterner, Till Opatz, Elke Richling, Hartmut Kleinert, Louis P. Sandjo, Andrea Pautz, Ulrich Förstermann, Johannes C. Liermann and Wölfgang Steglich and has published in prestigious journals such as Gastroenterology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Gerhard Erkel

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerhard Erkel Germany 21 514 442 289 186 156 66 1.2k
Siew Bee Ng Singapore 20 621 1.2× 396 0.9× 383 1.3× 93 0.5× 176 1.1× 53 1.4k
Toshifumi Takeuchi Japan 20 468 0.9× 244 0.6× 234 0.8× 104 0.6× 121 0.8× 69 991
Hai‐Yan Tian China 23 1.0k 2.0× 327 0.7× 234 0.8× 84 0.5× 121 0.8× 87 1.7k
Yongchun Shen United States 19 498 1.0× 284 0.6× 313 1.1× 77 0.4× 175 1.1× 47 1.0k
Toshihiko Nogawa Japan 21 846 1.6× 677 1.5× 274 0.9× 76 0.4× 223 1.4× 77 1.4k
Anup S. Pathania India 21 662 1.3× 186 0.4× 219 0.8× 166 0.9× 73 0.5× 50 1.2k
Young‐Joo Kim South Korea 23 1.0k 2.0× 205 0.5× 173 0.6× 130 0.7× 111 0.7× 55 1.6k
Midori A. Arai Japan 27 1.3k 2.6× 373 0.8× 877 3.0× 187 1.0× 144 0.9× 138 2.5k
Shreyans K. Jain India 22 569 1.1× 240 0.5× 376 1.3× 176 0.9× 49 0.3× 96 1.3k
Ahmed R. Hamed Egypt 19 507 1.0× 166 0.4× 230 0.8× 114 0.6× 97 0.6× 71 1.2k

Countries citing papers authored by Gerhard Erkel

Since Specialization
Citations

This map shows the geographic impact of Gerhard Erkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Erkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Erkel more than expected).

Fields of papers citing papers by Gerhard Erkel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Erkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Erkel. The network helps show where Gerhard Erkel may publish in the future.

Co-authorship network of co-authors of Gerhard Erkel

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Erkel. A scholar is included among the top collaborators of Gerhard Erkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Erkel. Gerhard Erkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meineck, Myriam, Wilfried Roth, Till Opatz, et al.. (2023). The macrocyclic lactone oxacyclododecindione reduces fibrosis progression. Frontiers in Pharmacology. 14. 1200164–1200164. 2 indexed citations
2.
Groß, Jonathan, et al.. (2023). Structure elucidation and biological activities of perylenequinones from an Alternaria species. Mycotoxin Research. 39(3). 303–316. 2 indexed citations
3.
Marx, Lisa, et al.. (2017). Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models. Frontiers in Physiology. 8. 566–566. 10 indexed citations
4.
Sandjo, Louis P., et al.. (2016). Anti-inflammatory tetraquinane diterpenoids from a Crinipellis species. Bioorganic & Medicinal Chemistry. 25(2). 514–522. 23 indexed citations
5.
Sandjo, Louis P., et al.. (2014). Anti-inflammatory drimane sesquiterpene lactones from an Aspergillus species. Bioorganic & Medicinal Chemistry. 22(11). 2912–2918. 15 indexed citations
6.
7.
Schmidt, Nadine, Julia Art, Anke Werner, et al.. (2012). The Anti-Inflammatory Fungal Compound (S)-Curvularin Reduces Proinflammatory Gene Expression in an In Vivo Model of Rheumatoid Arthritis. Journal of Pharmacology and Experimental Therapeutics. 343(1). 106–114. 24 indexed citations
8.
Hausding, Michael, Caroline Übel, Hans A. Lehr, et al.. (2010). Induction of tolerogenic lung CD4+ T cells by local treatment with a pSTAT-3 and pSTAT-5 inhibitor ameliorated experimental allergic asthma. International Immunology. 23(1). 1–15. 28 indexed citations
9.
Schollmeyer, Dieter, Gerhard Erkel, Timm Anke, et al.. (2008). Inhibitors of Inducible NO Synthase Expression: Total Synthesis of (S)‐Curvularin and Its Ring Homologues. ChemMedChem. 3(6). 924–939. 30 indexed citations
10.
Erkel, Gerhard, et al.. (2007). Influence of the fungal NF-κB inhibitor panepoxydone on inflammatory gene expression in MonoMac6 cells. International Immunopharmacology. 7(5). 612–624. 21 indexed citations
11.
Erkel, Gerhard, et al.. (2007). Imidazo[1,2-a]pyridine derivatives as inhibitors of TNF-α expression in T cells. Bioorganic & Medicinal Chemistry. 16(3). 1236–1241. 16 indexed citations
12.
13.
Erkel, Gerhard, et al.. (2004). Inhibition of inducible TNF-α expression by oxaspirodion, a novel spiro-compound from the ascomycete Chaetomium subspirale. Biological Chemistry. 385(9). 829–834. 10 indexed citations
14.
Erkel, Gerhard, et al.. (2003). S14-95, a Novel Inhibitor of the JAK/STAT Pathway from a Penicillium species. The Journal of Antibiotics. 56(4). 337–343. 13 indexed citations
15.
Erkel, Gerhard, et al.. (2000). The Irpexans, a New Group of Biologically Active Metabolites Produced by the Basidiomycete Irpex sp. 93028.. The Journal of Antibiotics. 53(10). 1137–1144. 8 indexed citations
16.
Anke, Timm, et al.. (2000). Inhibition of interleukin‐6 signaling by galiellalactone. FEBS Letters. 484(1). 1–6. 65 indexed citations
17.
Anke, Timm, et al.. (2000). Inhibition of Interleukin-6 Signaling and Stat3 Activation by a New Class of Bioactive Cyclopentenone Derivatives. Biochemical and Biophysical Research Communications. 276(2). 447–453. 22 indexed citations
18.
Erkel, Gerhard, et al.. (1998). Nitidon, a New Bioactive Metabolite from the Basidiomycete Junghuhnia nitida (Pers.: Fr.) Ryv.. Zeitschrift für Naturforschung C. 53(1-2). 89–92. 18 indexed citations
20.
Erkel, Gerhard, et al.. (1996). Nidulal, a Novel Inducer of Differentiation of Human Promyelocytic Leukemia Cells from Nidula candida.. The Journal of Antibiotics. 49(12). 1189–1195. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026